Breaking News Bar

Business News and Information

Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday

Swiss drugmaker Roche Holding plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics, it said, after winning U.S. regulatory approval for the long-delayed deal.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear